Aqemia

Aqemia

Scale Drug Discovery with Quantum-Inspired Physics and AI

Contact for Pricing

Description

Aqemia operates as a next-generation pharmatech company focused on significantly scaling the drug discovery process. It employs a distinctive technology that merges quantum-inspired physics algorithms, developed over 12 years of research, with advanced machine learning. Unlike conventional AI platforms that rely on existing experimental data for training, Aqemia generates its own data from the earliest stages using its unique physics calculations.

This approach allows Aqemia's physics algorithms to achieve unprecedented speed—reportedly 10,000 times faster—and accuracy. These calculations effectively guide the company's generative AI to rapidly identify innovative drug candidates. Aqemia aims to scale drug discovery projects similarly to tech projects, building a substantial pipeline of wholly or partly owned drug candidates destined for clinical trials via dedicated biotech spin-offs.

Key Features

Quantum-Inspired Physics Algorithms: Generates proprietary data without needing prior experimental data.

Generative AI for Drug Design: Physics-guided AI discovers innovative drug candidates rapidly.

High-Speed Calculation: Physics algorithms operate 10,000x faster for accelerated discovery.

Scalable Discovery Platform: Enables scaling drug discovery projects like tech projects.

Drug Pipeline Generation: Builds a rapidly growing pipeline from hit generation to vivo assays.

Use Cases

Accelerating early-stage drug discovery.

Identifying novel drug candidates with higher precision.

Generating proprietary therapeutic pipelines.

Scaling pharmaceutical research and development efforts.

Facilitating large-scale collaborations in drug development.

Description

Key Features

Use Cases

You Might Also Like

Autocalls.ai

QuiQuoty

SendEngage

Quuu

Tomorrow.io